On Monday, the U.S. Court of Appeals for the Third Circuit in Washington, D.C., ruled against Merck & Co., rejecting its ...

HHS Secretary Robert F. Kennedy Jr. has joined President Donald Trump in a renewed effort to challenge how the United States ...

With its ascent seemingly unstoppable in the last few years, automated cell therapy manufacturer Cellares is facing some ...

Daiichi Sankyo is promoting Ken Keller to lead a new globally integrated commercialization unit, putting the executive in ...

Hansa has operated as a commercial-stage drugmaker since 2020, when the European Union cleared the way for imlifidase for ...

Move over, Hollywood—the real stars of the show are the ones helping patients in hospitals across the country.  | Education ...

If at first you don’t succeed in gene therapy, then try, try again. | If at first you don’t succeed in gene therapy, then try ...

After more than 10 years in development, Regeneron secured a landmark approval for its monoclonal antibody garetosmab, now ...

Just eight months after it introduced its oral version of semaglutide for obesity, also known as the Wegovy pill, Novo ...

Eight months after more than doubling down on its construction of a $2 billion drug manufacturing facility in Holly Springs, ...

For patients living with Type 2 diabetes in the United Kingdom, a more convenient treatment option may be on the horizon ...

China's investigator-initiated trials, once praised for their speediness, have been drawn into scrutiny for a lack of ...